You have 9 free searches left this month | for more free features.

City

Beijing (2)

Denver (1)

Houston (1)

Nashville (1)

Sarasota (1)

Zhengzhou (1)

Condition

Esophageal Cancer (2)

Head and Neck Cancer (2)

Non-small Cell Lung Cancer (2)

Other Metastatic Solid Tumors (2)

Advanced Solid Tumor (1)

Esophageal Squamous Cell Carcinoma (1)

Head and Neck Squamous Cell Carcinoma (1)

Non Small Cell Lung Cancer (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

Jacobio Pharmaceuticals Co., Ltd. (3)

Collaborator

AbbVie (1)

Intervention

jab-3068 (3)

pd1 inhibitor (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

jab-3068

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC, Head Neck Cancer, Esophageal Cancer Trial in Beijing (JAB-3068)

Recruiting

Non-small Cell Lung Cancer
+3 more

JAB-3068

Beijing, Beijing, China
+4 more

Mar 11, 2022

Advanced Solid Tumor, Esophageal Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Beijing, Zhengzhou (JAB-3068, PD1

Recruiting

Advanced Solid Tumor
+3 more

JAB-3068
PD1 inhibitor

Beijing, Beijing, China
+2 more

Jul 26, 2021

NSCLC, Head Neck Cancer, Esophageal Cancer Trial in United States (JAB-3068)

Recruiting

Non-small Cell Lung Cancer
+3 more

JAB-3068

Denver, Colorado
+3 more

Mar 25, 2021